190 likes | 510 Views
Worldwide Epidemiology of NASH. NAFLD may be the most common form of chronic liver disease in USA, Australia, Asia and EuropeMcCullough AJ, 2002Mulhall BP 2002Clark JM 2003Farrell GC. 2003Ruhl 2003. . Global challenges in Liver Diseases 2006. Problems In Studying Epidemiology Of NAFLD And NASH.
E N D
1. How Common Is NAFLD In Asia Pacific And Is There Local Differences Deepak Amarapurkar
Consultant Gastroenterologist and hepatologist, Bombay hospital & medical research centre, Mumbai
2. Worldwide Epidemiology of NASH NAFLD may be the most common form of chronic liver disease in USA, Australia, Asia and Europe
McCullough AJ, 2002
Mulhall BP 2002
Clark JM 2003
Farrell GC. 2003
Ruhl 2003
4. Problems In Studying Epidemiology Of NAFLD And NASH Lack of definitive laboratory test
Studies dependence on different definitions
Published series with biopsy confirmation are selected cases that have presented to medical attention
Values of alcohol consumption in published series ranged from < 20 gm/week to <140 gm/week
5. Prevalence of fatty liver Estimated prevalence is 5 % of population
20 to 30 % adults in western countries have NAFLD of which 2 to 3 % are NASH
(Imaging & autopsy study)
Steatosis seen in 70 % obese & 35 % lean patients
NASH seen in 18.5 % obese & 2.7 % lean patients
Hepatology 2003
6. Problems in Assessing NAFLD In Asian Pacific Region Inaccurate evaluation of alcohol abuse
Infrequent use of liver test in general practice
Lack of presentation of asymptomatic individual
Burden of viral hepatitis
Reluctance to do liver biopsy
Lack of awareness of the severity
Pursued slowly progressive nature
Considered as a disease of affluence
Chitturi S, Farrell G, George J JGH 2004
7. Prevalence of NAFLD In General Population In Asian Pacific Region Name of the Percentage NAFLD inCountry Adults
Japan 9 30%
China 5 18%
Korea 18 %
India 5 28%
Indonesia 30%
Malaysia 17 %
Singapore 5%
8. Prevalence of NAFLD In General Population In Asian Pacific Region Name of the Percentage NAFLD inCountry Adults
Australia ) Lack of data, perception
Taiwan ) amongst the clinician around
Hongkong ) 10- 30%
Sri Lanka )
Philippines )
9. Studies on non alcoholic Fatty Liver Disease And Non-alcoholic steatohepatitis In Asia
10. Prevalence of Risk Factors For NAFLD in Asian Pacific Region Diabetes
Obesity
Metabolic Syndrome
11. Prevalence of NAFLD In High Risk Population In Asian Pacific Region Name of the Diabetes Obesity Dyslipidemia
country
Japan 40-50% 50-80% 42-58%
China 35% 70-80% 57%
Korea 35% 10-50% 26-35%
India 30-90% 15-20% NA
Indonesia 52% 47% 56%
16. Prevalence Of The Metabolic Syndrome In Asians
17. Increasing Incidence of NAFLD Has been well documented from studies in Japan and China
Almost all countries in Asian Pacific region have reported increased incidence of diabetes, obesity, central obesity and insulin resistance
18. NonAlcoholic Fatty Liver Disease Histopathologic Spectrum Steatosis Steatohepatitis
19. NASH In Asia Pacific Future Shock Western Eastern Population Population
Age at Presentation 4th 8th decade 4th 8th decade
Prevalence 20-30% -10%
Obesity 71% (30-100) 44% (12-89)
T2DM 28% (2-55) 34% (11-39)
Hyperlipidemia 38% (15-81) 41% (28-81)
Natural History Worse with Limited data severe firbosis
Chitturi Et al JGH 2004
20. THANK
YOU